GlassScriptPhysician profile
Michael John Bonidie
NPI 1912915786
$38,610.49
in general payments reported to CMS, 2019-2025
11 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $30.00 · 2021: $9,324 · 2022: $14K · 2023: $13K · 2024: $1,793 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Consulting Fee: $2,250 · Travel and Lodging: $2,228 · Food and Beverage: $2,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Consulting Fee | $2,250.00 |
| Travel and Lodging | $2,228.07 |
| Food and Beverage | $2,044.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $31,251.36 | 2021-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $5,393.93 | 2022-2024 | Ligasure, Signia, Eea |
| Asensus Surgical, INC. | $1,545.51 | 2019-2024 | |
| Activ Surgical, INC. | $145.37 | 2021-2022 | |
| Baxter Healthcare | $144.90 | 2024 | Perclot |
| Covidien LP | $30.00 | 2020 | |
| Boston Scientific Corporation | $23.89 | 2023 | |
| Axonics, INC. | $21.21 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.57 | 2019 | |
| Caldera Medical, INC | $19.40 | 2022 | |
| Abbvie INC. | $15.35 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bonidie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.